First Western Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-42,960
Closed -$1.37M 120
2015
Q2
$1.37M Buy
+42,960
New +$1.4M 0.44% 85
2015
Q1
Sell
-7,819
Closed -$231K 131
2014
Q4
$231K Sell
7,819
-4,414
-36% -$127K 0.07% 122
2014
Q3
$343K Sell
12,233
-27,279
-69% -$766K 0.1% 124
2014
Q2
$1.11M Buy
39,512
+606
+2% +$17.3K 0.37% 94
2014
Q1
$1.19M Buy
38,906
+10,121
+35% +$302K 0.42% 92
2013
Q4
$836K Buy
+28,785
New +$838K 0.29% 111

Other funds holding PFE

First Western Capital Management's PFE Position: Q3 2015 in Review

First Western Capital Management sold out of Pfizer (PFE) in Q3 2015, closing a stake of 42,960 shares — an estimated $1.37M sold.

First Western Capital Management first reported a position in PFE in Q4 2013 and held it in 6 quarters. The position peaked at $1.37M in Q2 2015. 1,879 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

  • First Western Capital Management reported no remaining Pfizer position as of Q3 2015 after selling out during the quarter.
  • First Western Capital Management sold 42,960 Pfizer shares in Q3 2015, an estimated $1.37M.
  • First Western Capital Management first reported a position in Pfizer in Q4 2013 and held it in 6 quarters.
  • First Western Capital Management's Pfizer position peaked at $1.37M in Q2 2015.
  • 1,879 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on First Western Capital Management's 13F filing for Q3 2015, filed 20 Oct 2015.